Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature
雌激素受体阳性、人表皮生长因子受体2阴性乳腺肿瘤患者，经80基因特征重新分类为基底型后，其新辅助化疗反应和5年预后存在显著差异
期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO.21.00463
Whitworth, Pat W; Beitsch, Peter D; Pellicane, James V; Baron, Paul L; Lee, Laura A; Dul, Carrie L; Murray, Mary K; Gittleman, Mark A; Budway, Raye J; Rahman, Rakhshanda Layeequr; Kelemen, Pond R; Dooley, William C; Rock, David T; Cowan, Kenneth H; Lesnikoski, Beth-Ann; Barone, Julie L; Ashikari, Andrew Y; Dupree, Beth B; Wang, Shiyu; Menicucci, Andrea R; Yoder, Erin B; Finn, Christine; Corcoran, Kate; Blumencranz, Lisa E; Audeh, William
